Min Young Kim

Dr. Min Young Kim

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
MKMin Young Kim
Min Young Kim
AAAnas Alkhabaz
Anas Alkhabaz
SSStephen J. Smith
Stephen J. Smith
YLYaping Joyce Liao
Yaping Joyce Liao
This case report highlights the importance of monitoring ocular health for patients starting on siponimod treatment, a sphingosine-1-phosphate receptor modulator, for relapsing-remitting multiple sclerosis. By showing how medication adverse events present in patients, we can revisit the current guidelines on ophthalmic evaluation recommendations. We report a 60-year-old patient who presented with unilateral blurry vision upon initiating siponimod therapy for the treatment of relapsing-remitting multiple sclerosis. Her exam findings did not show visual field defects but were significant for cystoid macular edema distorting the foveal contour. Upon stopping siponimod therapy, the patient's macular edema and symptoms resolved significantly within 7 days and completely resolved 1 month later. This case showcases siponimod-associated cystoid macular edema in a patient without known risk factors, such as diabetes mellitus and uveitis. The patient also had the earliest reported symptom onset to date following the initiation of siponimod therapy. Current recommendations from the American Academy of Ophthalmology and FDA stress the importance of ophthalmic evaluation three to four months after treatment initiation for patients with a history of risk factors. Given our current case and its comparison with four previously reported cases, we recommend that physicians inform patients of possible ocular adverse events with siponimod therapy regardless of their past medical history and duration of treatment.

14 October 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
MKMin Young Kim
Min Young Kim
NKNandini Koneru
Nandini Koneru
GAGieth Alahdab
Gieth Alahdab
MRMichael Risner
Michael Risner
AIAhmed Ibrahim
Ahmed Ibrahim
Mohamed Al-ShabraweyMohamed Al-Shabrawey
Mohamed Al-Shabrawey
Traumatic optic neuropathy (TON) causes vision loss through compression and contusion, yet there is no consensus on the most effective treatment. Polyunsaturated fatty acid (PUFA)-derived bioactive lipids metabolized by lipoxygenase (LOX), cytochrome P450 (CYP), and cyclooxygenase (COX) enzymes are known mediators of inflammation and neurodegeneration. However, their role in TON-related retinal pathology remains unclear. Controlled orbital impact (COI) was used to induce unilateral TON in mice with controlled velocity (2–3 m/s), with the fellow eye serving as an internal control. Retina tissues were collected three days post-injury and analyzed by LC/MS to quantify bioactive lipid metabolites from ω−6 and ω−3 PUFAs. Statistical analysis was performed using paired, nonparametric Wilcoxon signed-rank tests with Benjamini–Hochberg false discovery rate (FDR) correction. Results showed that among 38 reliably detected metabolites, no individual lipid showed a statistically significant difference between TON and control eyes after FDR correction (q < 0.05). However, both individual and pathway-level analysis revealed consistent trends toward increased expression of LOX- and CYP-derived metabolites across FDA PUFA substrates, including arachidonic acid (AA), linoleic acid (LA), and docosahexaenoic acid (DHA). These findings support further investigation into lipid-mediated inflammation in TON and its potential as a therapeutic target, particularly through expanding both the sample size and the post-TON time periods.

30 May 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
BCBenton Chuter
Benton Chuter
NENoah Emmert
Noah Emmert
MKMin Young Kim
Min Young Kim
ASAndrew B. Stiemke
Andrew B. Stiemke
NDNikhil Dave
Nikhil Dave
MJMonica Jablonski
Monica Jablonski
Machine learning approaches for automated quantification of optic nerve histology have emerged as tools for the objective assessment of axonal injury in experimental glaucoma models. However, their generalizability to independent datasets remains unclear. Guided by a scoping review following PRISMA-ScR guidelines, this study evaluated the performance of publicly available models on novel datasets. PubMed, EMBASE, Scopus, and Cochrane CENTRAL were searched (2000–2025). Two reviewers screened studies and extracted model characteristics and performance metrics. Three models (AxoNet, AxonDeepSeg, and AxoNet 2.0) were independently validated on a rat optic nerve dataset (44 images; 6941 axons) and a mouse optic nerve dataset (74 full cross-sections). From 2036 records, four manuscripts describing three deep learning models met the inclusion criteria, with reported correlation coefficients of 0.959–0.99 between model predictions and reference counts. On the rat dataset, the performance correlation declined (r = 0.831–0.907), precision remained high (>0.94), but recall was low (0.18–0.27), with Dice coefficients of 0.29–0.40. On the mouse dataset, correlations decreased further (r = 0.57–0.74) and model rankings differed, reflecting the domain shift and scale-dependent effects. These findings demonstrate strong within-study performance but reduced generalizability to independent datasets, highlighting the need for standardized validation datasets and multi-center testing.

16 September 2025 in Cancer Medicine
Verified
Journal Article
Open access
ZCZaria N. Cosby
Zaria N. Cosby
JHJulian P. Howland
Julian P. Howland
EBEleanor Brown
Eleanor Brown
LCLucas K. Carpenter
Lucas K. Carpenter
KDKristen M. Davis‐Lopez
Kristen M. Davis‐Lopez
ADAaron J. Dawes
Aaron J. Dawes
Background: Psychological distress increases after a cancer diagnosis. However, patients who identify as Hispanic/Latino are less likely than their White counterparts to receive mental health care after being diagnosed, placing them at risk of poor psychological adjustment. The parent research objective aimed to characterize the treatment experiences of rectal cancer patients who identify as Hispanic/Latino. This qualitative secondary analysis specifically explored patients' emotional and psychological experiences. Methods: We partnered with local community health workers to recruit rectal cancer patients who identified as Hispanic/Latino and their caregivers from California's Bay Area and Central Valley. Semi‐structured interviews ( n = 21) were conducted in either Spanish or English based on patient preference. Initial themes were identified using reflexive analysis. Experiences of distress were found in nearly all interviews, motivating this qualitative secondary analysis using directed content analysis. Results: We identified three main themes: (1) emotional reactions to the initial diagnosis, (2) perspectives and emotions experienced throughout treatment, and (3) coping strategies and advice for others. Participants reported shock and incongruence with their diagnosis. The treatment journey caused feelings of embarrassment and frustration from difficulties such as racial profiling and insurance. Patients coped through faith and support from trusted individuals. Conclusions: Rectal cancer patients who identify as Hispanic/Latino endure emotional distress at multiple stages of their cancer journey, including from sources that are unique to this population. Culturally and linguistically tailored interventions are needed to help mitigate this psychological burden and to provide active, coordinated support throughout the treatment phase in order to better prepare patients for survivorship.

25 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBenton Chuter
Benton Chuter
WWWilliam White
William White
THT.J. Hollingsworth
T.J. Hollingsworth
XWXiangDi Wang
XiangDi Wang
LGLinan Guan
Linan Guan
MJMonica Jablonski
Monica Jablonski
Objective: To determine whether non-axon optic nerve morphometric features correlate with clinical visual function as strongly as the traditional axon count gold standard. Design: Cross-sectional histological analysis with longitudinal clinical correlation. Subjects: Eighteen mice from three strains: C57BL/6J (n=6), BXD51 (n=6), and DBA/2J (n=6). Methods: Left eye (OS) optic nerves from mice euthanized at 12 months of age were resin-embedded and stained with p-phenylenediamine. Bright-field cross-sectional images were segmented using an AxonDeepSeg-based workflow to generate axon, myelin, whole nerve, and glial coverage masks for morphometric quantification. Seven morphometrics were extracted: axon count (nAx), axon density (AxDen), glial coverage area ratio (GliaR), mean solidity (Sol), mean axon diameter (AxDiam), mean myelin area (MyArea), and mean axon-myelin area (AxMyArea). Morphometrics were correlated with longitudinal clinical data collected at 1, 3, 6, 9, and 12 months, including visual acuity (VA), contrast threshold, intraocular pressure (IOP), and pattern electroretinography P50 and N95 amplitudes (PERG P50 and N95). Main Outcome Measures: Pearson correlation coefficients were used to assess associations between morphometric features and clinical measures, and Fisher z-transformed meta-analytic correlations were used to aggregate these associations across ages. Results: VA and contrast threshold demonstrated strong correlations with GliaR that matched or exceeded nAx. Meta-analysis across ages revealed GliaR correlated with VA (r = -0.84, p = 4.49 × 10 -21 ) and contrast threshold (r = 0.86, p =7.55 × 10- 23 ), comparable to nAx correlations with VA (r = 0.80, p =8.13×10 -17 ) and contrast threshold (r = -0.80, p= 1.74×10 -16 ). Structure-function relationships shifted with age: at 6 months, GliaR had the strongest correlation with contrast threshold (r = 0.96), while at 12 months, AxDiam became the dominant correlate of both VA (r = 0.77) and contrast threshhold (r = -0.74). IOP, PERG P50, and PERG N95 exhibited weak correlations with all morphometrics (|r| < 0.27). Conclusions: Non-axon morphometrics, particularly glial coverage area ratio, correlate with visual function as strongly as traditional axon count. Automated optic nerve assessment should incorporate glial and other non-axon features. Further, stage-aware biomarker selection may better capture structure-function relationships in glaucoma.

13 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBenton Chuter
Benton Chuter
NENoah Emmert
Noah Emmert
MKMin Young Kim
Min Young Kim
NDNikhil Dave
Nikhil Dave
JHJay Herrin
Jay Herrin
MJMonica Jablonski
Monica Jablonski
Purpose: Machine learning approaches for automated quantification of optic nerve histology have emerged as potential tools for objective assessment of axonal injury in experimental glaucoma models. However, the generalizability of these models to independent datasets remains unclear. Guided by a scoping review of the literature, this study performed independent validation testing of publicly available models on a novel rat optic nerve dataset to assess their generalizability. Methods: We conducted a scoping review following PRISMA-ScR guidelines. PubMed, EMBASE, Scopus, and Cochrane CENTRAL were searched from 2000 through 2025. Two reviewers independently screened records and extracted data on model characteristics and performance metrics. Additionally, we performed independent validation of three models (AxoNet, AxonDeepSeg, AxoNet 2.0) on a novel rat optic nerve dataset comprising 57 images with 9,514 manually annotated axons. Because AxonDeep is not publicly available, we instead evaluated AxonDeepSeg, a separate publicly available deep learning-based tool that, while not previously applied to optic nerve tissue, is widely used for nerve fiber segmentation. Results: From 2,036 records, four manuscripts describing three deep learning models met inclusion criteria. Published correlation coefficients between model predictions and reference counts ranged from 0.959 to 0.99. On independent validation, performance was reduced: AxoNet 2.0 achieved the highest correlation (r = 0.89), followed by AxonDeepSeg (r = 0.86) and AxoNet (r = 0.79). Segmentation quality metrics revealed high precision (>0.94) but low recall (0.18 to 0.27), with Dice coefficients of 0.29 to 0.40, substantially below published benchmarks of 0.81. Conclusions: Deep learning models for optic nerve histology demonstrate strong within-study performance but show meaningful performance decrements when applied to independent datasets. The observed generalizability gap (correlations 0.07 to 0.182 points below published values) demonstrates the need for standardized validation datasets and multi-center testing before widespread adoption of these tools.